Wilkinson, David J 
ORCID: 0000-0002-6262-3575, Habgood, Angela, Lamb, Heather K, Thompson, Paul, Hawkins, Alastair R, Désilets, Antoine, Leduc, Richard, Steinmetzer, Torsten, Hammami, Maya, Lee, Melody S et al (show 5 more authors)
(2017)
Matriptase Induction of Metalloproteinase-Dependent Aggrecanolysis In Vitro and In Vivo: Promotion of Osteoarthritic Cartilage Damage by Multiple Mechanisms.
Arthritis & Rheumatology, 69 (8).
pp. 1601-1611.
Abstract
Objective To assess the ability of matriptase, a type II transmembrane serine proteinase, to promote aggrecan loss from the cartilage of patients with osteoarthritis (OA) and to determine whether its inhibition can prevent aggrecan loss and cartilage damage in experimental OA. Methods Aggrecan release from human OA cartilage explants and human stem cell–derived cartilage discs was evaluated, and cartilage‐conditioned media were used for Western blotting. Gene expression was analyzed by real‐time polymerase chain reaction. Murine OA was induced by surgical destabilization of the medial meniscus, and matriptase inhibitors were administered via osmotic minipump or intraarticular injection. Cartilage damage was scored histologically and aggrecan cleavage was visualized immunohistochemically using specific neoepitope antibodies. Results The addition of soluble recombinant matriptase promoted a time‐dependent release of aggrecan (and collagen) from OA cartilage, which was sensitive to metalloproteinase inhibition and protease‐activated receptor 2 antagonism. Although engineered human (normal) cartilage discs failed to release aggrecan following matriptase addition, both matrix metalloproteinase– and aggrecanase‐mediated cleavages of aggrecan were detected in human OA cartilage. Additionally, while matriptase did not directly degrade aggrecan, it promoted the accumulation of low‐density lipoprotein receptor–related protein 1 (LRP‐1) in conditioned media of the OA cartilage explants. Matriptase inhibition via neutralizing antibody or small molecule inhibitor significantly reduced cartilage damage scores in murine OA, which was associated with reduced generation of metalloproteinase‐mediated aggrecan cleavage. Conclusion Matriptase potently induces the release of metalloproteinase‐generated aggrecan fragments as well as soluble LRP‐1 from OA cartilage. Therapeutic targeting of matriptase proteolytic activity reduces metalloproteinase activity, further suggesting that this serine proteinase may have potential as a disease‐modifying therapy in OA.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Cartilage, Articular, Menisci, Tibial, Animals, Humans, Mice, Osteoarthritis, Knee, Endopeptidases, Matrix Metalloproteinases, Serine Endopeptidases, Membrane Proteins, Recombinant Proteins, Blotting, Western, Immunohistochemistry, Gene Expression Profiling, Aged, Aged, 80 and over, Middle Aged, Female, Male, Aggrecans, Antibodies, Neutralizing, Low Density Lipoprotein Receptor-Related Protein-1, Real-Time Polymerase Chain Reaction, In Vitro Techniques, ADAMTS4 Protein, ADAMTS5 Protein |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 02 Jul 2020 08:44 |
| Last Modified: | 18 Jan 2023 23:47 |
| DOI: | 10.1002/art.40133 |
| Open Access URL: | https://doi.org/10.1002/art.40133 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3092425 |
Dimensions
Dimensions
